Menu

Gain Therapeutics, Inc. GANX

Full chart Compare
Set alert

Price alert · GANX

All alert types
1.09 USD +0.06 (+5.83%)

At closeNov 9, 2026, 7:13 PM EST

1.09 0.00 0.00%

After hours · Nov 9, 7:13 PM ET

1.00 Day range 1.12
0.94 52-week range 4.34
YTD
-66.15%
1 year
-44.39%

Revenue & Expenses

Other Income → Expenses: $64.89KExpenses → Selling, General & Admin: $10.79MExpenses → Research & Development: $11.52MExpenses → Income Tax: $79.28KGross Profit → Expenses: $55.18KRevenue → Gross Profit: $55.18KNet Loss → Expenses: $22.27MOther Income$64.89KGross Profit$55.18KNet Loss$22.27MExpenses$22.39MSelling, General & Admin$10.79MResearch & Development$11.52MIncome Tax$79.28KRevenue$55.18K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

GANX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
18.71M20.35M22.31M17.92M13.99M
10.21M10.79M11.52M8.38M7.16M
8.50M9.56M10.79M9.54M6.83M
-18.71M-20.35M-22.25M-17.78M-13.83M
861.12K536.82K79.28K92.98K4.01K
-20.16M-20.41M-22.27M-17.59M-13.89M
-20.16M-20.41M-22.27M-17.59M-13.89M
-20.16M-20.41M-22.27M-17.59M-13.89M
-20.16M-20.41M-22.27M-17.59M-13.89M
-0.61-0.89-1.71-1.48-1.37
-0.61-0.89-1.71-1.48-1.37
-0.61-0.89-1.71-1.48-1.37
-19.30M-19.87M-22.19M-17.50M-13.89M
-19.30M-19.87M-22.19M-17.50M-13.89M
32.97M22.88M13.01M11.88M10.17M
32.97M22.88M13.01M11.88M10.17M